MORGAN STANLEY

Position in CNSY — Cerenome, Inc.

CIK 895421 NEW YORK, NY

Position in CNSY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$808

+$808 QoQ

Shares Held

185

+1750.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 22 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. CNSY ranks #473 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$808	185	+1750.0%	Shares	Defined	2026-08-13
2023-03-31	—	10	+400.0%	Shares	Defined	2023-05-15
2022-12-31	—	2	-66.7%	Shares	Defined	2023-02-14
2022-09-30	—	6	-100.0%	Shares	Defined	2022-11-14
2022-06-30	—	118,427	-3.2%	Shares	Defined	2022-10-27
2022-03-31	—	122,279	+3192.4%	Shares	Defined	2022-10-27
2021-12-31	—	3,714	+9673.7%	Shares	Defined	2022-02-14
2021-09-30	—	38	0.0%	Shares	Defined	2021-11-15
2021-06-30	—	38	-76.8%	Shares	Defined	2021-08-23
2021-03-31	—	164	+256.5%	Shares	Defined	2021-05-17
2020-12-31	—	46	-2.1%	Shares	Defined	2021-02-16
2020-09-30	—	47	-2.1%	Shares	Defined	2020-11-13
2020-06-30	—	48	+140.0%	Shares	Defined	2020-08-14
2020-03-31	—	20	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.